GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » Net Margin %

Alembic Pharmaceuticals (BOM:533573) Net Margin % : 11.75% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Alembic Pharmaceuticals's Net Income for the three months ended in Mar. 2024 was ₹1,782 Mil. Alembic Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was ₹15,170 Mil. Therefore, Alembic Pharmaceuticals's net margin for the quarter that ended in Mar. 2024 was 11.75%.

The historical rank and industry rank for Alembic Pharmaceuticals's Net Margin % or its related term are showing as below:

BOM:533573' s Net Margin % Range Over the Past 10 Years
Min: 6.05   Med: 13.84   Max: 23.72
Current: 9.89


BOM:533573's Net Margin % is ranked better than
69.15% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.2 vs BOM:533573: 9.89

Alembic Pharmaceuticals Net Margin % Historical Data

The historical data trend for Alembic Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals Net Margin % Chart

Alembic Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.45 21.73 9.96 6.05 9.89

Alembic Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.85 8.11 8.56 11.07 11.75

Competitive Comparison of Alembic Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alembic Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Alembic Pharmaceuticals's Net Margin % falls into.



Alembic Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Alembic Pharmaceuticals's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=6158.2/62286.3
=9.89 %

Alembic Pharmaceuticals's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=1782.1/15169.8
=11.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alembic Pharmaceuticals  (BOM:533573) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Alembic Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alembic Pharmaceuticals (BOM:533573) Business Description

Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (BOM:533573) Headlines

No Headlines